The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
lupus
New England Journal of Medicine publishes lupus drug trial paper authored by OMRF expert
Clinical trial results illustrate incremental advances in lupus research.
OMRF’s lupus cohort marks 20 years
Tens of thousands of patient samples have contributed to worldwide research.
Life Changer: Oklahoma’s lupus cohort marks 20 years
Oklahoma’s lupus cohort marks 20 years.
Eureka Moments
The new millennium began with a bang at OMRF, as Dr. Jordan Tang, above, and his research team identified and cloned the enzyme believed to cause Alzheimer’s disease. Soon after, the OMRF scientists designed an inhibitor that stopped the enzyme in its tracks. The discoveries led to the development of an experimental drug acquired by […]
Making A Mark
A patent provides its owner with an exclusive right to a new invention. And beginning in the 1990s, the U.S. Patent and Trademark Office granted a multitude to OMRF, sometimes more than a dozen in a single year. Only a decade earlier did Congress give OMRF and others the right to patent inventions that stemmed […]
